KRAS and lung adenocarcinoma: Studies have shown that some patients with LCCA may harbor molecular mutations, including EGFR, KRAS, and ALK gene rearrangements, which are more commonly found in NSCLC, particularly in lung adenocarcinoma (16, 25).